| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | IMBIO LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4403 | HENNEPIN | USA | R44HL145953 | Vascular Deformation Mapping (VDM) for Automated, 3D Assessment of Thoracic Aortic Aneurysm | 000 | 4 | NIH | 2/9/2024 | $0 |
| | 2024 | 2022 | IMBIO LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4403 | HENNEPIN | USA | R43HL162396 | A CT-Based Multiparametric Imaging Biomarker for Assessment of Pediatric Interstitial Lung Disease | 000 | 1 | NIH | 2/20/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = -$2,500 ) |
| | 2023 | 2022 | IMBIO, LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4402 | HENNEPIN | USA | R43HL162396 | A CT-Based Multiparametric Imaging Biomarker for Assessment of Pediatric Interstitial Lung Disease | 000 | 1 | NIH | 11/23/2022 | -$2,500 |
| | 2023 | 2022 | IMBIO, LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4402 | HENNEPIN | USA | R43HL162396 | A CT-Based Multiparametric Imaging Biomarker for Assessment of Pediatric Interstitial Lung Disease | 001 | 1 | NIH | 12/21/2022 | $0 |
| | 2023 | 2021 | IMBIO LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4403 | HENNEPIN | USA | R44HL140894 | Commercialization of a CT-based Technique for BOS Assessment | 000 | 4 | NIH | 9/6/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $665,672 ) |
| | 2022 | 2022 | IMBIO, LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4402 | HENNEPIN | USA | R44HL145953 | Vascular Deformation Mapping (VDM) for Automated, 3D Assessment of Thoracic Aortic Aneurysm | 000 | 4 | NIH | 4/29/2022 | $449,666 |
| | 2022 | 2022 | IMBIO, LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4402 | HENNEPIN | USA | R43HL162396 | A CT-Based Multiparametric Imaging Biomarker for Assessment of Pediatric Interstitial Lung Disease | 000 | 1 | NIH | 9/6/2022 | $251,508 |
| | 2022 | 2018 | IMBIO, LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4402 | HENNEPIN | USA | R44CA203050 | Personalized Smoking Cessation Tool Based on Patient Lung CT Image | 000 | 4 | NIH | 5/6/2022 | -$35,502 |
|
| Issue Date FY: 2021 ( Subtotal = $909,494 ) |
| | 2021 | 2021 | IMBIO, LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4402 | HENNEPIN | USA | R44HL145953 | Vascular Deformation Mapping (VDM) for Automated, 3D Assessment of Thoracic Aortic Aneurysm | 000 | 3 | NIH | 5/22/2021 | $449,666 |
| | 2021 | 2021 | IMBIO, LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4402 | HENNEPIN | USA | R44HL140894 | Commercialization of a CT-based Technique for BOS Assessment | 001 | 4 | NIH | 5/20/2021 | $459,828 |
| | 2021 | 2020 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44HL140894 | Commercialization of a CT-based Technique for BOS Assessment | 000 | 3 | NIH | 11/6/2020 | $0 |
| | 2021 | 2019 | IMBIO, LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4402 | HENNEPIN | USA | R44CA210825 | Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment | 001 | 4 | NIH | 5/20/2021 | -$21,962 |
| | 2021 | 2018 | IMBIO, LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4402 | HENNEPIN | USA | R44CA203050 | Personalized Smoking Cessation Tool Based on Patient Lung CT Image | 000 | 4 | NIH | 9/16/2021 | $0 |
| | 2021 | 2017 | IMBIO, LLC | 1015 GLENWOOD AVE | MINNEAPOLIS | MN | 55405-4402 | HENNEPIN | USA | R44CA210825 | Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment | 000 | 2 | NIH | 5/19/2021 | $21,962 |
|
| Issue Date FY: 2020 ( Subtotal = $930,271 ) |
| | 2020 | 2020 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44HL140894 | Commercialization of a CT-based Technique for BOS Assessment | 002 | 3 | NIH | 5/15/2020 | $480,278 |
| | 2020 | 2020 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44HL145953 | Vascular Deformation Mapping (VDM) for Automated, 3D Assessment of Thoracic Aortic Aneurysm | 002 | 2 | NIH | 9/24/2020 | $8,348 |
| | 2020 | 2020 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44HL145953 | Vascular Deformation Mapping (VDM) for Automated, 3D Assessment of Thoracic Aortic Aneurysm | 000 | 2 | NIH | 4/28/2020 | $449,993 |
| | 2020 | 2019 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44HL140894 | Commercialization of a CT-based Technique for BOS Assessment | 001 | 2 | NIH | 2/13/2020 | $0 |
| | 2020 | 2019 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44HL145953 | Vascular Deformation Mapping (VDM) for Automated, 3D Assessment of Thoracic Aortic Aneurysm | 001 | 1 | NIH | 9/24/2020 | -$8,348 |
| | 2020 | 2018 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44HL140894 | Commercialization of a CT-based Technique for BOS Assessment | 000 | 1 | NIH | 2/13/2020 | $0 |
| | 2020 | 2018 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44CA203050 | Personalized Smoking Cessation Tool Based on Patient Lung CT Image | 000 | 4 | NIH | 8/7/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,065,452 ) |
| | 2019 | 2019 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44CA210825 | Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment | 000 | 4 | NIH | 9/5/2019 | $480,745 |
| | 2019 | 2019 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44HL140894 | Commercialization of a CT-based Technique for BOS Assessment | 000 | 2 | NIH | 5/31/2019 | $553,577 |
| | 2019 | 2019 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44HL145953 | Vascular Deformation Mapping (VDM) for Automated, 3D Assessment of Thoracic Aortic Aneurysm | 000 | 1 | NIH | 5/1/2019 | $166,890 |
| | 2019 | 2018 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R43HL139273 | Automated coronary artery calcification scoring for cardiovascular risk screening | 000 | 1 | NIH | 7/31/2019 | -$26,561 |
| | 2019 | 2016 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44CA180425 | Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer Diagnosis | 000 | 4 | NIH | 4/26/2019 | -$109,199 |
|
| Issue Date FY: 2018 ( Subtotal = $1,337,595 ) |
| | 2018 | 2018 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44HL140894 | Commercialization of a CT-based Technique for BOS Assessment | 000 | 1 | NIH | 7/27/2018 | $223,973 |
| | 2018 | 2018 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44CA210825 | Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment | 000 | 3 | NIH | 8/20/2018 | $489,069 |
| | 2018 | 2018 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R43HL139273 | Automated coronary artery calcification scoring for cardiovascular risk screening | 000 | 1 | NIH | 6/26/2018 | $224,403 |
| | 2018 | 2018 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44CA203050 | Personalized Smoking Cessation Tool Based on Patient Lung CT Image | 000 | 4 | NIH | 8/28/2018 | $400,151 |
| | 2018 | 2016 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R44CA180425 | Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer Diagnosis | 000 | 4 | NIH | 8/13/2018 | $0 |
| | 2018 | 2015 | IMBIO, LLC | 807 BROADWAY ST NE #350 | MINNEAPOLIS | MN | 55413-4401 | HENNEPIN | USA | R43CA203050 | Personalized Smoking Cessation Tool based on patient lung CT image | 000 | 1 | NIH | 5/23/2018 | -$1 |
|
| Issue Date FY: 2017 ( Subtotal = $1,097,976 ) |
| | 2017 | 2017 | IMBIO, LLC | 807 BDWY ST NE #350 | MINNEAPOLIS | MN | 55413 | HENNEPIN | USA | R44CA210825 | Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment | 001 | 2 | NIH | 9/15/2017 | $497,459 |
| | 2017 | 2017 | IMBIO, LLC | 807 BDWY ST NE #350 | MINNEAPOLIS | MN | 55413 | HENNEPIN | USA | R44CA203050 | Personalized Smoking Cessation Tool Based on Patient Lung CT Image | 000 | 3 | NIH | 8/8/2017 | $622,479 |
| | 2017 | 2016 | IMBIO, LLC | 807 BDWY ST NE #350 | MINNEAPOLIS | MN | 55413 | HENNEPIN | USA | R44HL118837 | CT-based Biomarker for Diagnosis of COPD Phenotypes and Disease Progression | 000 | 4 | NIH | 5/9/2017 | $0 |
| | 2017 | 2016 | IMBIO, LLC | 807 BDWY ST NE #350 | MINNEAPOLIS | MN | 55413 | HENNEPIN | USA | R44CA210825 | Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment | 000 | 1 | NIH | 8/17/2017 | -$21,962 |
|
| Issue Date FY: 2016 ( Subtotal = $1,781,283 ) |
| | 2016 | 2016 | IMBIO LLC | 227 COLFAX AVENUE NORTH | MINNEAPOLIS | MN | 55405 | HENNEPIN | USA | R44CA203050 | Personalized Smoking Cessation Tool Based on Patient Lung CT Image | 000 | 2 | NIH | 9/21/2016 | $464,633 |
| | 2016 | 2016 | IMBIO LLC | 227 COLFAX AVENUE NORTH | MINNEAPOLIS | MN | 55405 | HENNEPIN | USA | R44CA210825 | Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment | 000 | 1 | NIH | 8/22/2016 | $222,255 |
| | 2016 | 2016 | IMBIO LLC | 227 COLFAX AVENUE NORTH | MINNEAPOLIS | MN | 55405 | HENNEPIN | USA | R44CA180425 | Commercialization of the Shutter-Speed Model for Dynamic MRI in Cancer Diagnosis | 000 | 4 | NIH | 7/4/2016 | $541,200 |
| | 2016 | 2016 | IMBIO LLC | 227 COLFAX AVENUE NORTH | MINNEAPOLIS | MN | 55405 | HENNEPIN | USA | R44HL118837 | CT-based Biomarker for Diagnosis of COPD Phenotypes and Disease Progression | 000 | 4 | NIH | 3/7/2016 | $553,195 |
|
| Issue Date FY: 2015 ( Subtotal = $1,289,813 ) (Continued on the next page) |
|
